Sun S, et al. Bifidobacterium alters the gut microbiota and modulates the functional metabolism of T regulatory cells in the context of immune checkpoint blockade. Proc Natl Acad Sci USA. 2020;117(44):27509–15.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Mortezaee K, Majidpoor J. Alternative immune checkpoints in immunoregulatory profile of cancer stem cells. Heliyon. 2023;605:728.

Google Scholar 

Mair F, et al. Extricating human tumour immune alterations from tissue inflammation. Nature. 2022;605(7911):728–35.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Schumann K, et al. Functional CRISPR dissection of gene networks controlling human regulatory T cell identity. Nat Immunol. 2020;21(11):1456–66.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Park T-Y, et al. Co-transplantation of autologous Treg cells in a cell therapy for Parkinson’s disease. Nature. 2023;619(7970):606–15.

Article  ADS  CAS  PubMed  Google Scholar 

Bittner S, et al. Biosensors for inflammation as a strategy to engineer regulatory T cells for cell therapy. Proc Natl Acad Sci USA. 2022;119(40): e2208436119.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rana J, et al. CAR-and TRuC-redirected regulatory T cells differ in capacity to control adaptive immunity to FVIII. Mol Ther. 2021;29(9):2660–76.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhu AX, et al. Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma. Nat Med. 2022;28(8):1599–611.

Article  CAS  PubMed  Google Scholar 

Xydia M, et al. Common clonal origin of conventional T cells and induced regulatory T cells in breast cancer patients. Nat Commun. 2021;12(1):1119.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Chuckran CA, et al. Prevalence of intratumoral regulatory T cells expressing neuropilin-1 is associated with poorer outcomes in patients with cancer. Sci Transl Med. 2021. https://doi.org/10.1126/scitranslmed.abf8495.

Article  PubMed  PubMed Central  Google Scholar 

Wight AE, et al. Antibody-mediated blockade of the IL23 receptor destabilizes intratumoral regulatory T cells and enhances immunotherapy. Proc Natl Acad Sci USA. 2022;119(18): e2200757119.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martinez RJ, et al. Type III interferon drives thymic B cell activation and regulatory T cell generation. Proc Natl Acad Sci USA. 2023;120(9): e2220120120.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Matheu MP, et al. Imaging regulatory T cell dynamics and CTLA4-mediated suppression of T cell priming. Nat Commun. 2015;6(1):6219.

Article  ADS  CAS  PubMed  Google Scholar 

Seif F, et al. Breast cancer tumor microenvironment affects Treg/IL-17-producing Treg/Th17 cell axis: molecular and therapeutic perspectives. Mol Ther Oncol. 2023;28:132.

Article  CAS  Google Scholar 

Sakaguchi S. Naturally arising Foxp3-expressing CD25+ CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol. 2005;6(4):345–52.

Article  CAS  PubMed  Google Scholar 

Ghosh S, et al. The transcription factor Foxp1 preserves integrity of an active Foxp3 locus in extrathymic Treg cells. Nat Commun. 2018;9(1):4473.

Article  ADS  PubMed  PubMed Central  Google Scholar 

Somasundaram R, et al. Tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapy. Nat Commun. 2021;12(1):346.

Article  CAS  PubMed  PubMed Central  Google Scholar 

van Hooren L, et al. CD103+ regulatory T cells underlie resistance to radio-immunotherapy and impair CD8+ T cell activation in glioblastoma. Nat Cancer. 2023. https://doi.org/10.1038/s43018-023-00547-6.

Article  PubMed  PubMed Central  Google Scholar 

Mortezaee K. Myeloid-derived suppressor cells in cancer immunotherapy-clinical perspectives. Life Sci. 2021;277: 119627.

Article  CAS  PubMed  Google Scholar 

Lauder SN, et al. Treg-driven tumour control by PI3Kδ inhibition limits myeloid-derived suppressor cell expansion. Br J Cancer. 2022;127(9):1595–602.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Śledzińska A, et al. Regulatory T cells restrain interleukin-2-and Blimp-1-dependent acquisition of cytotoxic function by CD4+ T cells. Immunity. 2020;52(1):151–66.

Article  PubMed  PubMed Central  Google Scholar 

Huang H, et al. Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancer. Cancer Cell. 2022;40(6):656–73.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Costa A, et al. Fibroblast heterogeneity and immunosuppressive environment in human breast cancer. Cancer Cell. 2018;33(3):463–79.

Article  CAS  PubMed  Google Scholar 

Sun R, et al. Amphiregulin couples IL1RL1+ regulatory T cells and cancer-associated fibroblasts to impede antitumor immunity. Sci Adv. 2023. https://doi.org/10.1126/sciadv.add7399.

Article  PubMed  PubMed Central  Google Scholar 

Sun W, et al. A positive-feedback loop between tumour infiltrating activated Treg cells and type 2-skewed macrophages is essential for progression of laryngeal squamous cell carcinoma. Br J Cancer. 2017;117(11):1631–43.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kitz A, Dominguez-Villar M. Molecular mechanisms underlying Th1-like Treg generation and function. Cell Mol Life Sci. 2017;74:4059–75.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Halim L, et al. An atlas of human regulatory T helper-like cells reveals features of Th2-like Tregs that support a tumorigenic environment. Cell Rep. 2017;20(3):757–70.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Van Gool F, et al. A mutation in the transcription factor Foxp3 drives T helper 2 effector function in regulatory T cells. Immunity. 2019;50(2):362–77.

Article  PubMed  PubMed Central  Google Scholar 

Junius S, et al. Unstable regulatory T cells, enriched for naïve and Nrp1neg cells, are purged after fate challenge. Sci Immunol. 2021. https://doi.org/10.1126/sciimmunol.abe4723.

Article  PubMed  Google Scholar 

Xu Y, et al. Induction of Foxp3 and activation of Tregs by HSP gp96 for treatment of autoimmune diseases. iScience. 2021. https://doi.org/10.1016/j.isci.2021.103445.

Article  PubMed  PubMed Central  Google Scholar 

Hunt MS, et al. Dual-locus, dual-HDR editing permits efficient generation of antigen-specific, regulatory T cells with robust suppressive activity. Mol Ther. 2023. https://doi.org/10.1016/j.ymthe.2023.07.016.

Article  PubMed  Google Scholar 

Shi LZ. Trimming the “fatty” intratumoral Tregs for cancer immunotherapy. Sci Transl Med. 2020. https://doi.org/10.1126/scitranslmed.abb2770.

Article  PubMed  PubMed Central  Google Scholar 

Wang H, et al. CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors. Nat Immunol. 2020;21(3):298–308.

Article  PubMed  PubMed Central  Google Scholar 

Zhu G-Q, et al. CD36+ cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor. Cell Discovery. 2023;9(1):25.

Article  MathSciNet  CAS  PubMed  PubMed Central  Google Scholar 

Yang P, et al. CD36-mediated metabolic crosstalk between tumor cells and macrophages affects liver metastasis. Nat Commun. 2022;13(1):5782.

Article  ADS  MathSciNet  CAS